JD Health International Inc. (6618)

Basic

  • Market Cap

    HK$118.62B

  • EV

    HK$64.9B

  • Shares Out

    3,188.62M

  • Revenue

    CN¥53.62B

  • Employees

    2,751

Margins

  • Gross

    21.78%

  • EBITDA

    1.54%

  • Operating

    1.28%

  • Pre-Tax

    4.01%

  • Net

    3.2%

  • FCF

    7.38%

Returns (5Yr Avg)

  • ROA

    4.46%

  • ROE

    -146%

  • ROCE

    10.27%

  • ROIC

    6.8%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    HK$54.7

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    CN¥17.22

  • Earnings (Dil)

    CN¥0.54

  • FCF

    CN¥1.25

  • Book Value

    CN¥15.31

Growth (CAGR)

  • Rev 3Yr

    54.18%

  • Rev 5Yr

    53.12%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    -43.85%

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    17.27%

  • EBITDA Fwd 2Yr

    275.29%

  • EPS Fwd 2Yr

    28.76%

  • EPS LT Growth Est

    27.57%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM
Metric
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

8,169.1

10,842.1

19,382.6

30,682.3

46,736.2

53,621.3

Total Revenues % Chg.

47.1%

32.7%

78.8%

58.3%

52.3%

43.9%

Cost of Goods Sold, Total

6,190.1

8,029.9

14,465.3

23,485.0

36,844.6

41,941.3

Gross Profit

1,979.0

2,812.3

4,917.3

7,197.3

9,891.5

11,679.9

Selling General & Admin Expenses, Total

1,453.6

2,040.6

3,956.5

7,670.1

8,871.3

9,645.8

Provision for Bad Debts

4.4

1.9

0.1

38.4

98.2

151.8

R&D Expenses

218.3

338.2

609.1

892.9

1,067.2

1,197.2

Other Operating Expenses, Total

1,676.2

2,380.7

4,565.7

8,601.3

10,036.6

10,994.9

Operating Income

302.7

431.6

351.6

-1,404.0

-145.1

685.1

Interest Expense, Total

-0.2

-35.5

-3.4

-6.0

-9.1

-8.6

Interest And Investment Income

0.1

31.8

149.1

457.6

864.3

1,580.1

Net Interest Expenses

-0.1

-3.7

145.7

451.6

855.2

1,571.5

Income (Loss) On Equity Invest.

—

—

-77.0

-94.2

-96.8

-80.4

Other Non Operating Income (Expenses)

3.6

-1,262.6

-17,492.4

145.1

82.5

-26.4

EBT, Excl. Unusual Items

306.2

-834.7

-17,072.1

-901.5

695.8

2,149.7

EBT, Incl. Unusual Items

306.2

-834.7

-17,072.1

-901.5

695.8

2,149.7

Income Tax Expense

91.3

137.1

162.8

171.3

312.6

427.4

Earnings From Continuing Operations

214.9

-971.8

-17,234.9

-1,072.8

383.2

1,722.3

Minority Interest

—

—

0.5

-0.7

-3.1

-4.4

Net Income

214.9

-971.8

-17,234.4

-1,073.5

380.1

1,717.9

Net Income to Common Incl Extra Items

214.9

-971.8

-17,234.4

-1,073.5

380.1

1,717.9

Net Income to Common Excl. Extra Items

214.9

-971.8

-17,234.4

-1,073.5

380.1

1,717.9

Total Shares Outstanding

—

2,149.3

3,184.4

3,098.1

3,106.2

3,179.9

Weighted Avg. Shares Outstanding

—

2,149.3

2,208.5

3,094.9

3,106.9

3,113.3

Weighted Avg. Shares Outstanding Dil

—

2,149.3

2,208.5

3,094.9

3,144.4

3,155.8

EPS

—

-0.5

-7.8

-0.3

0.1

0.6

EPS Diluted

—

-0.5

-7.8

-0.4

0.1

0.5

EBITDA

307.4

436.9

364.5

-1,371.6

-60.9

826.2